Antibody-drug conjugates in lung and breast cancer: Current evidence and future directions – a position statement from the ETOP IBCSG Partners Foundation

Post time 2024-4-24 07:49:38

journal：Annals of Oncology

Authors：S. Peters; S. Loi; F. André; S. Chandarlapaty; E. Felip; S.P. Finn; P.A. Janne; K.M. Kerr; E. Munzone; A. Passaro; M. Pérol; E.F. Smit; C. Swanton; G. Viale; R.A. Stahel

Published date：2024-4-

DOI：10.1016/j.annonc.2024.04.002

PDF link：https://www.sciencedirect.com/sc ... 92375342400108X/pdf

Article link：http://dx.doi.org/10.1016/j.annonc.2024.04.002

Article Source：Elsevier BV。

Remark：

Post time 2024-4-24 07:49:39

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Elsevier] Antibody-drug conjugates in lung and breast cancer: Current evidence and future directions – a position statement from the ETOP IBCSG Partners Foundation

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Antibody-drug conjugates in lung and breast cancer: Current evidence and future directions – a position statement from the ETOP IBCSG Partners Foundation Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Elsevier] Antibody-drug conjugates in lung and breast cancer: Current evidence and future directions – a position statement from the ETOP IBCSG Partners Foundation